Safety and Efficacy of Flecainide in Subjects with Long QT‐3 Syndrome (ΔKPQ Mutation): A Randomized, Double‐Blind, Placebo‐Controlled Clinical Trial

Background: We conducted a study of chronic therapy with flecainide versus placebo in a small group of LQT‐3 patients with the ΔKPQ deletion to evaluate the safety and efficacy of flecainide in this genetic disorder. In vitro studies have shown that flecainide provides correction of the impaired ina...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Ann Noninvasive Electrocardiol
Päätekijät: Moss, Arthur J., Windle, John R., Hall, W. Jackson, Zareba, Wojciech, Robinson, Jennifer L, McNitt, Scott, Severski, Patricia, Rosero, Spencer, Daubert, James P., Qi, Ming, Cieciorka, Michael, Manalan, Allan S.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Blackwell Publishing, Inc. 2005
Aiheet:
Original Articles
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6932190/
https://ncbi.nlm.nih.gov/pubmed/16274417
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1542-474X.2005.00077.x
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia